Clinical trial
The Utility of MRI Scoring to Predict Neurodevelopmental Outcomes in Survivors
NCT02249624 is registered in ClinicalTrials.gov with Catherine Cibulskis, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Utility of MRI Scoring to Predict Neurodevelopmental Outcomes in Survivors
- Lead sponsor
- Catherine Cibulskis, MD
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- May 30, 2024
- Enrollment
- 51 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.